In the 12 months since President Barack Obama took office, health care reform has been a major concern for both the White House and Congress. One part of the proposed overhaul is an emphasis on quality care at reasonable prices. This involves continued and increased research -- known as comparative effectiveness research -- on the outcomes and effectiveness of different drugs, therapies and procedures. Comparative effectiveness research directly compares existing health care interventions to determine which procedures work best for various patient populations and which pose the greatest benefits and harms.
This discussion is the second event in the Medicine, Research and Society Public Policy Issues Series, a joint project between the Baker Institute Science and Technology Policy Program and The University of Texas M. D. Anderson Cancer Center. Additional sponsors for this event include the Baker Institute Health Policy Forum and the Rice University Institute of Biosciences and Bioengineering.